312-422-1111 [email protected]
  • Stay Updated
  • Become a Member
  • Business Solutions
  • iBIO Connect
  • Contact Us
iBIO
  • About
    • Introduction
    • Leadership
    • Contact
  • PROGRAMS
    • Overview
    • LabShare
    • STEMKits
    • StellarGirls
    • BioGENEius Illinois
  • Advocacy
    • Overview
    • Advocacy Center
    • Advocacy Toolkit
    • Rare Disease
  • News & Events
    • News
    • Events
    • Daily Newsletter
    • Walbert Award
  • Member Resources
    • Member Benefits
    • Business Solutions
    • Member Committees
    • Join iBIO
      • Discover our Community
  • Illinois Industry
    • About Illinois
    • Resource Map
    • State Incentives
Select Page
Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy

Global Plasma Leaders Collaborate to Accelerate Development of Potential COVID-19 Hyperimmune Therapy

by John Conrad | Apr 6, 2020 | COVID, Member News

Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19 Biotest, BPL, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and...
Takeda’s BioLife Plasma Services is looking for healthy individuals who have recovered from COVID-19

Takeda’s BioLife Plasma Services is looking for healthy individuals who have recovered from COVID-19

by John Conrad | Mar 31, 2020 | COVID, Member News

BioLife Plasma Services, part of Takeda, has implemented a unique protocol for collecting plasma from healthy individuals who have recovered from COVID-19 to enable development of a potential therapy for COVID-19, made from human plasma. You can read more about this...
  • Home
  • About Us
  • Business Solutions
  • Advocacy
  • News
  • Join iBIO
  • Contact Us
  • Facebook
  • X
  • RSS
© 2022 iBIO | All Rights Reserved | Powered by BIRKEY.COM
X